U.S. FDA warns GSK over problems at Quebec flu vaccine manufacturing plant
TORONTO - The company that makes much of Canada's annual flu vaccine has received a warning from the U.S. Food and Drug Administration.
GSK received a letter of warning from the FDA about conditions at its manufacturing facility at Ste-Foy, Que., where the company makes flu vaccine for the Canadian and U.S. markets.
The warning stems from an inspection of the plant conducted by FDA agents earlier this year.
The letter says the facility deviates from current good manufacturing practice requirements, the industry standards enforced by licensing agencies.
The letter raises concerns about the purified water system at the plant and other issues and gives the company 15 days in which to address the problems.
A statement from GSK says the company is making progress addressing the FDA's concerns and is committed to working with the regulatory agency to fully resolve all outstanding issues.
Read more Business News
- Girl abducted, sexually assaultedBC
- 102nd birthday boat cruiseKelowna
- Downtown hotel, what's in a nameKelowna - 5:00 am
- Fundraising effort with a twistKelowna
|QHR Technologies Inc||1.19||0.00|
|Anavex Life Sciences||0.25||+0.01|
|Copper Mountain Mining||2.96||+0.05|
|Sunrise Resources Ltd||0.025||0.00|
|Mission Ready Services||0.23||-0.02|
Apple has taught many entrepreneurs the importance of design, how to create buzz when introducing new products to the marketplace, how to pioneer new technology and the importance of superior quality....
Move over “big guys” there’s a new brokerage in town featuring local expertise, long standing experience and a fresh boutique approach. Kelowna, August 31 2014 – You may have...
There are several things to consider when deciding how much home to buy. 1. Draw up a budget including the new mortgage payments. While the rules used by most lenders require that the mortgage paym...